LBA6 PACIFIC-5: A phase III study of consolidation durvalumab (D) in patients (pts) with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy (cCRT or sCRT)Yi‐Long Wu, Lin Wang, Chung‐Li Wang et al.|Annals of Oncology|2024Cited by 8
Impaired decision-making under risk in patients with functional dyspepsiaShenshen Zhang, Yanghua Tian, Lihong Wu et al.|Journal of Clinical and Experimental Neuropsychology|2020Cited by 6
Impaired pain empathic abilities among patients with functional dyspepsiaXiangpeng Hu, Yanghua Tian, Lijiu Zhang et al.|Cognitive Neuropsychiatry|2021Cited by 3